← Open Payments lookup

CANDISS TRAGER: Open Payments

NPI 1881117679 · KYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,072 in 129 payments from 16 companies in 2025. Trend: 2023 $1,633 · 2024 $2,474 · 2025 $3,072

Food & beverage: $2,442Consulting: $630
CompanyPaymentsAmount
GENZYME CORPORATION17$1,051
GlaxoSmithKline, LLC.48$498
AstraZeneca Pharmaceuticals LP14$428
Regeneron Healthcare Solutions, Inc.12$350
United Therapeutics Corporation13$229
Verona Pharma, Inc.6$145
Electromed, Inc.4$76
Grifols USA, LLC4$66
Takeda Pharmaceuticals U.S.A., Inc.2$43
Boehringer Ingelheim Pharmaceuticals, Inc.2$42

Products named: DUPIXENT, NUCALA, FASENRA, TRELEGY ELLIPTA, Tyvaso, Ohtuvayre, AIRSUPRA, SMARTVEST.

Industry payments across TX — which companies pay providers there.